Related Experiment Video
Updated: Jun 15, 2025

11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.6K
miR-142 regulates the function of microvascular endothelial cells through MAT2B
Chun-Yu Liu1, Dun-Chao Chen2, Zi-Hang Zhang3
1Department of Burn and Plastic Surgery, General Hospital of Northern Theater Command, Shenyang, China.
Archives of Biochemistry and Biophysics
|June 11, 2025
Summary
Inhibiting microRNA-142-5p protects the blood-brain barrier (BBB) from inflammatory damage by restoring tight junction proteins and reducing inflammation markers. This suggests miR-142-5p downregulation is a potential therapy for BBB dysfunction.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Astrocytes are crucial for blood-brain barrier (BBB) integrity.
- Inflammation disrupts the BBB by affecting tight junction proteins (TJPs).
- MicroRNA-142 (miR-142) links brain inflammation and neuronal dysfunction.
Purpose of the Study:
- To investigate the role of miR-142-5p in regulating astrocyte-brain microvascular endothelial cell (BMVEC) interactions under inflammation.
- To determine if inhibiting miR-142-5p can mitigate inflammatory BBB damage.
Main Methods:
- Simulated inflammatory conditions using lipopolysaccharide (LPS)-induced astrocytic media (L-ACM).
- Assessed the impact of miR-142 inhibition on BMVECs.
- Measured expression of TJPs, Bcl-2/Bax ratio, NF-κB levels, and potential miR-142-5p targets like MAT2B.
Main Results:
- miR-142 inhibition alleviated LPS-induced BMVEC disruption.
- Inhibition upregulated TJPs and the Bcl-2/Bax ratio.
- NF-κB levels were downregulated, potentially via MAT2B interaction.
Conclusions:
- Downregulation of miR-142-5p shows therapeutic potential for inflammatory BBB damage.
- Targeting miR-142-5p may restore BBB integrity by modulating inflammatory pathways and TJPs.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K

